Key result
Higher early sST2 levels post-AMI correlate with lower LVEF at 24 weeks.
Why the study?
Serum sST2 levels are elevated early after AMI and associated with lower pre-discharge LVEF and adverse outcomes, but their relationship with serial changes in LV function was unknown.
Does serum soluble ST2 level predict left ventricular functional recovery in patients with acute myocardial infarction and LV systolic dysfunction?
Population
100 patients admitted with AMI and resultant LV systolic dysfunction
Comparison
Serial serum sST2 levels over time
Design
Prospective observational study
Follow-up
24 weeks
Authors
Loading...
sST2 may aid post-MI LV recovery prediction; extends biomarker correlations with serial CMR but requires outcome validation.
Observational (n=100)
Does serum soluble ST2 level predict left ventricular functional recovery in patients with acute myocardial infarction and LV systolic dysfunction?
Effect estimate: r = -0.23
p-value: p=0.026
Measurement of sST2 early after acute myocardial infarction assists in predicting medium-term left ventricular functional recovery and infarct remodeling.
Weir et al. (2010) conducted an observational in Acute myocardial infarction with LV systolic dysfunction (n=100). Serum sST2 levels was evaluated on Correlation between serum sST2 and left ventricular ejection fraction at 24 weeks (r = -0.23, p=0.026). Serum sST2 levels measured early after acute myocardial infarction correlated significantly with left ventricular ejection fraction at 24 weeks (r = -0.23, p = 0.026).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: